arrow
M

Marjolijn J. L. Ligtenberg

human genetics
H指数:69
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Crisis readiness for rare disease populations: learnings and recommendations by the European Reference Networks

罕见病人群的危机准备:欧洲参考网络的经验与建议

2026-08-080
OA
Evaluation of homologous recombination testing in ovarian carcinoma

同源重组检测在卵巢癌中的评估

2026-02-070
OAAI
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study

在PROMPT研究中,早期转移性去势抵抗性前列腺癌患者的分子反射测试

2025-10-310
OA
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer

转移性前列腺癌患者中胚系致病性变异的流行率

2025-09-020
OAAI
Germline Pathogenic Variants in Patients with Pancreatic Ductal Adenocarcinoma and Extra-Pancreatic Malignancies: A Nationwide Database Analysis

胰腺导管腺癌和胰外恶性肿瘤患者的种系致病变异: 全国性数据库分析

2025-05-010
OAAI
Combining whole blood RNA-sequencing (WB-RNA) and circulating tumor DNA (ctDNA) for the early identification of patients (pts) without clinical benefit to immune checkpoint inhibitors (ICI) in metastatic urothelial cancer (mUC)

结合全血RNA测序(WB-RNA)和循环肿瘤DNA(ctDNA),以早期识别对免疫检查点抑制剂(ICI)无临床获益的转移性尿路上皮癌(mUC)患者(pts)。

2024-09-010
PRE
Nivolumab 3mg/kg and ipilimumab 1mg/kg (nivo3/ipi1) in molecularly selected patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

纳武利尤单抗3mg/kg和伊匹木单抗1mg/kg(nivo3/ipi1)在分子筛选的患者(pts)中用于治疗转移性去势抵抗性前列腺癌(mCRPC)

2024-09-010
PRE
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer

均聚物开关介导错配修复缺陷型结直肠癌的适应性可变性

2024-07-031
OAAI
Genomic instability in non-breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1/2

在BRCA1/2中具有种系致病性变异的个体的非乳腺或卵巢恶性肿瘤中的基因组不稳定性

2024-07-031
OAAI
The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2

CHEK2中双等位基因种系致病变异个体的异质性癌症表型

2024-05-011
OAAI
Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer

晚期尿路上皮癌治疗早期循环肿瘤DNA测量和对免疫检查点抑制剂的反应

2024-04-012
OA
External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium
2024-03-140
OA